Back to top Open menu arrow
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Clinical Research Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, New York
  2. Department of Psychiatry, New York University School of Medicine, New York, New York
  3. Corresponding author: Dan V. Iosifescu, MD, MSc, Nathan Kline Institute, 140 Old Orangeburg Rd, Orangeburg, NY 10962 ([email protected]).
  4. Department of Psychological Science, University of Vermont, Burlington, Vermont
  5. Clinical Research Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, New York
  6. Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts
  7. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  8. Clinical Research Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, New York
  9. Clinical Research Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, New York
  10. LiteCure LLC, New Castle, Delaware
  11. Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts
  12. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  13. Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts
  14. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  15. Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts
  16. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  17. Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts
  18. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  19. Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts
  20. Department of Public Health, Harvard Medical School, Boston, Massachusetts
  21. Laser Research Centre, Faculty of Health Science, University of Johannesburg, Johannesburg, South Africa
  22. Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts
  23. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  24. Division of Neuropsychiatry, Massachusetts General Hospital, Boston, Massachusetts
  1. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services, RTI International. Results from the 2017 National Survey on Drug Use and Health: Detailed Tables. SAMHSA website. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.htm#tab8-56A. Published 2017.
  2. Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Med. 2013;10(11):e1001547. PubMed CrossRef
  3. Barrett B, Byford S, Knapp M. Evidence of cost-effective treatments for depression: a systematic review. J Affect Disord. 2005;84(1):1–13. PubMed CrossRef
  4. Lampl Y, Zivin JA, Fisher M, et al. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke. 2007;38(6):1843–1849. PubMed CrossRef
  5. Huisa BN, Stemer AB, Walker MG, et al; NEST-1 and -2 investigators. Transcranial laser therapy for acute ischemic stroke: a pooled analysis of NEST-1 and NEST-2. Int J Stroke. 2013;8(5):315–320. PubMed CrossRef
  6. Hacke W, Schellinger PD, Albers GW, et al; NEST 3 Committees and Investigators. Transcranial laser therapy in acute stroke treatment: results of Neurothera effectiveness and safety trial 3, a phase III clinical end point device trial. Stroke. 2014;45(11):3187–3193. PubMed CrossRef
  7. Hamblin MR. Shining light on the head: photobiomodulation for brain disorders. BBA Clin. 2016;6:113–124. PubMed CrossRef
  8. Zhang Q, Ma H, Nioka S, et al. Study of near infrared technology for intracranial hematoma detection. J Biomed Opt. 2000;5(2):206–213. PubMed CrossRef
  9. Mochizuki-Oda N, Kataoka Y, Cui Y, et al. Effects of near-infra-red laser irradiation on adenosine triphosphate and adenosine diphosphate contents of rat brain tissue. Neurosci Lett. 2002;323(3):207–210. PubMed CrossRef
  10. Cassano P, Tran AP, Katnani H, et al. Selective photobiomodulation for emotion regulation: model-based dosimetry study. Neurophotonics. 2019;6(1):015004. PubMed CrossRef
  11. Yuan Y, Cassano P, Pias M, et al. Transcranial photobiomodulation with near-infrared light from childhood to elderliness: simulation of dosimetry. Neurophotonics. 2020;7(1):015009. PubMed CrossRef
  12. Eells JT, Henry MM, Summerfelt P, et al. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci U S A. 2003;100(6):3439–3444. PubMed CrossRef
  13. Harper DG, Jensen JE, Ravichandran C, et al. Tissue type-specific bioenergetic abnormalities in adults with major depression. Neuropsychopharmacology. 2017;42(4):876–885. PubMed CrossRef
  14. Iosifescu DV, Bolo NR, Nierenberg AA, et al. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry. 2008;63(12):1127–1134. PubMed CrossRef
  15. Cassano P, Cusin C, Mischoulon D, et al. Near-infrared transcranial radiation for major depressive disorder: proof of concept study. Psychiatry J. 2015;2015:352979. PubMed CrossRef
  16. Schiffer F, Johnston AL, Ravichandran C, et al. Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct. 2009;5(1):46. PubMed CrossRef
  17. Cassano P, Petrie SR, Mischoulon D, et al. Transcranial photobiomodulation for the treatment of major depressive disorder. The ELATED-2 Pilot Trial. Photomed Laser Surg. 2018;36(12):634–646. PubMed CrossRef
  18. Cassano P, Caldieraro MA, Norton R, et al. Reported side effects, weight and blood pressure, after repeated sessions of transcranial photobiomodulation. Photobiomodul Photomed Laser Surg. 2019;37(10):651–656. PubMed CrossRef
  19. Cassano P, Dording C, Thomas G, et al. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction. Lasers Surg Med. 2019;51(2):127–135. PubMed CrossRef
  20. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22–33, quiz 34–57. PubMed
  21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. PubMed CrossRef
  22. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266–1277. PubMed CrossRef
  23. Chandler GM, Iosifescu DV, Pollack MH, et al. RESEARCH: validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther. 2010;16(5):322–325. PubMed CrossRef
  24. Jöbsis-VanderVliet FF, Piantadosi CA, Sylvia AL, et al. Near-infrared monitoring of cerebral oxygen sufficiency, I: apectra of cytochrome c oxidase. Neurol Res. 1988;10(1):7–17. PubMed CrossRef
  25. Jagdeo JR, Adams LE, Brody NI, et al. Transcranial red and near infrared light transmission in a cadaveric model. PLoS One. 2012;7(10):e47460. PubMed CrossRef
  26. Sharma SK, Kharkwal GB, Sajo M, et al. Dose response effects of 810 nm laser light on mouse primary cortical neurons. Lasers Surg Med. 2011;43(8):851–859. PubMed CrossRef
  27. Barrett DW, Gonzalez-Lima F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans. Neuroscience. 2013;230:13–23. PubMed CrossRef
  28. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–583. PubMed CrossRef
  29. Fava M, Evins AE, Dorer DJ, et al. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom. 2003;72(3):115–127. PubMed CrossRef
  30. Schoenfeld DA. SPCDAnalyze: Design and Analyze Studies Using the Sequential Parallel Comparison Design. CRAN R Project website. https://CRAN.R-project.org/package=SPCDAnalyze. 2019. Accessed August 18, 2020.
  31. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. R Project website. https://www.R-project.org/. 2020.
  32. Salehpour F, Cassano P, Rouhi N, et al. Penetration profiles of visible and near-infrared lasers and light-emitting diode light through the head tissues in animal and human species: a review of literature. Photobiomodul Photomed Laser Surg. 2019;37(10):581–595. PubMed CrossRef
  33. Salehpour F, Majdi A, Pazhuhi M, et al. Transcranial photobiomodulation improves cognitive performance in young healthy adults: a systematic review and meta-analysis. Photobiomodul Photomed Laser Surg. 2019;37(10):635–643. PubMed CrossRef
  34. Caldieraro MA, Cassano P. Transcranial and systemic photobiomodulation for major depressive disorder: a systematic review of efficacy, tolerability and biological mechanisms. J Affect Disord. 2019;243:262–273. PubMed CrossRef
  35. Disner SG, Beevers CG, Gonzalez-Lima F. Transcranial laser stimulation as neuroenhancement for attention bias modification in adults with elevated depression symptoms. Brain Stimul. 2016;9(5):780–787. PubMed CrossRef
  36. Salehpour F, Gholipour-Khalili S, Farajdokht F, et al. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review. Rev Neurosci. 2020;31(3):269–286. PubMed CrossRef
  37. Hamper M, Cassano P, Lombard J. Treatment of Kleine-Levin syndrome with intranasal photobiomodulation and methylene blue. Cureus. 2021;13(10):e18596. PubMed CrossRef
  38. Sonawalla SB, Rosenbaum JF. Placebo response in depression. Dialogues Clin Neurosci. 2002;4(1):105–113. PubMed CrossRef
  39. Brunoni AR, Lopes M, Kaptchuk TJ, et al. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis. PLoS One. 2009;4(3):e4824. PubMed CrossRef
Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

Save Save

Share Share

Cite Cite

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe now